Harmony Biosciences Holdings Stock Buy Hold or Sell Recommendation
| HRMY Stock | USD 39.54 0.72 1.85% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Harmony Biosciences Holdings is 'Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Harmony Biosciences Holdings given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Harmony Biosciences Holdings, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Harmony Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Harmony and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Harmony Biosciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Harmony |
Execute Harmony Biosciences Buy or Sell Advice
The Harmony recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Harmony Biosciences Holdings. Macroaxis does not own or have any residual interests in Harmony Biosciences Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Harmony Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Harmony Biosciences Trading Alerts and Improvement Suggestions
| Harmony Biosciences has a strong financial position based on the latest SEC filings | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Sandip Kapadia Sells 1,775 Shares of Harmony Biosciences Holdings, Inc. Stock - MarketBeat |
Harmony Biosciences Returns Distribution Density
The distribution of Harmony Biosciences' historical returns is an attempt to chart the uncertainty of Harmony Biosciences' future price movements. The chart of the probability distribution of Harmony Biosciences daily returns describes the distribution of returns around its average expected value. We use Harmony Biosciences Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Harmony Biosciences returns is essential to provide solid investment advice for Harmony Biosciences.
| Mean Return | 0.30 | Value At Risk | -4.1 | Potential Upside | 3.62 | Standard Deviation | 3.77 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Harmony Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Harmony Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Harmony Biosciences, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Harmony Biosciences Holdings back and forth among themselves.
| Shares | Geode Capital Management, Llc | 2024-09-30 | 735.4 K | Massachusetts Financial Services Company | 2024-09-30 | 660.4 K | Venbio Partners Llc | 2024-09-30 | 614.6 K | Federated Hermes Inc | 2024-09-30 | 542.1 K | Renaissance Technologies Corp | 2024-09-30 | 492.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 371.4 K | D. E. Shaw & Co Lp | 2024-09-30 | 355.9 K | Marshall Wace Asset Management Ltd | 2024-09-30 | 350.6 K | Cambria Investment Management, L.p. | 2024-09-30 | 331.6 K | Valor Management Llc | 2024-09-30 | 11.2 M | Blackrock Inc | 2024-09-30 | 5.7 M |
Harmony Biosciences Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (2.7M) | (609K) | 135K | (1.1M) | (1.2M) | (1.3M) | |
| Investments | (2.0M) | (100.3M) | (141.8M) | (57.3M) | (51.5M) | (54.1M) | |
| Change In Cash | 204.2M | 5.7M | 9.5M | 67.4M | 77.5M | 81.4M | |
| Free Cash Flow | (5.0M) | (1.7M) | 104.3M | 219.1M | 251.9M | 264.5M | |
| Depreciation | 10.2M | 18.8M | 23.4M | 24.4M | 28.0M | 14.7M | |
| Other Non Cash Items | 4.9M | 2.7M | 3.5M | 12.9M | 11.6M | 10.8M | |
| Capital Expenditures | 2.0M | 100.3M | 40.2M | 312K | 280.8K | 266.8K | |
| Net Income | (36.9M) | 34.6M | 181.5M | 128.9M | 148.2M | 155.6M | |
| End Period Cash Flow | 229.4M | 235.1M | 244.5M | 311.9M | 358.7M | 207.2M | |
| Change To Netincome | 64.4M | 32.9M | 42.3M | (58.2M) | (52.4M) | (49.8M) |
Harmony Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Harmony Biosciences or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Harmony Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Harmony stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 0.77 | |
σ | Overall volatility | 2.17 | |
Ir | Information ratio | 0.05 |
Harmony Biosciences Volatility Alert
Harmony Biosciences Holdings exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Harmony Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Harmony Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Harmony Biosciences Fundamentals Vs Peers
Comparing Harmony Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Harmony Biosciences' direct or indirect competition across all of the common fundamentals between Harmony Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Harmony Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Harmony Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Harmony Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Harmony Biosciences to competition |
| Fundamentals | Harmony Biosciences | Peer Average |
| Return On Equity | 0.23 | -0.31 |
| Return On Asset | 0.13 | -0.14 |
| Profit Margin | 0.18 % | (1.27) % |
| Operating Margin | 0.33 % | (5.51) % |
| Current Valuation | 2.03 B | 16.62 B |
| Shares Outstanding | 57.03 M | 571.82 M |
| Shares Owned By Insiders | 11.62 % | 10.09 % |
| Shares Owned By Institutions | 93.89 % | 39.21 % |
| Number Of Shares Shorted | 5.53 M | 4.71 M |
| Price To Earning | 293.37 X | 28.72 X |
| Price To Book | 3.78 X | 9.51 X |
| Price To Sales | 3.31 X | 11.42 X |
| Revenue | 582.02 M | 9.43 B |
| Gross Profit | 536.32 M | 27.38 B |
| EBITDA | 221.51 M | 3.9 B |
| Net Income | 128.85 M | 570.98 M |
| Cash And Equivalents | 254.17 M | 2.7 B |
| Cash Per Share | 4.30 X | 5.01 X |
| Total Debt | 193.57 M | 5.32 B |
| Debt To Equity | 0.79 % | 48.70 % |
| Current Ratio | 4.91 X | 2.16 X |
| Book Value Per Share | 10.46 X | 1.93 K |
| Cash Flow From Operations | 219.39 M | 971.22 M |
| Short Ratio | 9.84 X | 4.00 X |
| Earnings Per Share | 2.11 X | 3.12 X |
| Target Price | 54.25 | |
| Number Of Employees | 246 | 18.84 K |
| Beta | 0.77 | -0.15 |
| Market Capitalization | 2.26 B | 19.03 B |
| Total Asset | 811.45 M | 29.47 B |
| Retained Earnings | (143.28 M) | 9.33 B |
| Working Capital | 287.29 M | 1.48 B |
| Net Asset | 811.45 M |
Note: Disposition of 1775 shares by Kapadia Sandip of Harmony Biosciences at 38.0548 subject to Rule 16b-3 [view details]
Harmony Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Harmony . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 11526.55 | |||
| Daily Balance Of Power | 0.595 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 39.32 | |||
| Day Typical Price | 39.39 | |||
| Price Action Indicator | 0.58 | |||
| Period Momentum Indicator | 0.72 |
About Harmony Biosciences Buy or Sell Advice
When is the right time to buy or sell Harmony Biosciences Holdings? Buying financial instruments such as Harmony Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Harmony Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large & Mid Caps ETFs Thematic Idea Now
Large & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large & Mid Caps ETFs theme has 67 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Harmony Stock Analysis
When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.